Smokers seeking to conquer their addiction may have a new treatment option following the results from a clinical trial led by Monash University, which found a combination of varenicline and nicotine lozenges significantly improved smoking abstinence when compared with varenicline alone. The work is published in the journal JAMA Network Open. Both varenicline and nicotine lozenges (a form of nicotine replacement therapy) are medications commonly used for smoking cessation. Varenicline is the most effective single therapy currently available for smoking cessation. The trial, titled “VANISH” (Varenicline And NIcotine replacement therapy Read More